• 1. Enzyme-purification and catalytic transformations in a microstructured PASSflow reactor using a new tyrosine-based Ni-NTA linker system attached to a polyvinylpyrrolidinone-based matrix
  Gerald Dr?ger,Csilla Kiss,Ulrich Kunz,Andreas Kirschning Org. Biomol. Chem. 2007 5 3657
• 2. Trimethylsilyl iodide as a peptide deblocking agent
  Richard S. Lott,Virander S. Chauhan,Charles H. Stammer J. Chem. Soc. Chem. Commun. 1979 495

• Solvents and Organic Chemicals Organic Compounds Acids/Esters

Professional Introduction of (R)-2-Amino-3-(4-(Benzyloxy)Phenyl)Propanoic Acid (CAS No. 65733-15-5)

The compound (R)-2-Amino-3-(4-(benzyloxy)phenyl)propanoic acid, identified by the CAS registry number 65733-15-5, is a structurally complex amino acid derivative with significant potential in various fields, including pharmaceuticals, biotechnology, and material science. This compound has garnered attention due to its unique chemical properties and promising applications in drug development and bioactive molecule synthesis.

Recent advancements in chemical synthesis have enabled researchers to explore the full potential of this compound. For instance, studies published in 2023 have highlighted its role as a key intermediate in the synthesis of bioactive molecules, particularly in the development of peptide-based drugs. The benzyloxy group attached to the phenyl ring introduces steric and electronic effects that enhance the compound's stability and bioavailability, making it an attractive candidate for drug delivery systems.

The stereochemistry of this compound, specifically the R configuration at the second carbon atom, plays a crucial role in its biological activity. Research has shown that this configuration significantly influences the compound's interaction with target proteins, thereby affecting its pharmacokinetic properties. This has led to increased interest in using this compound as a chiral building block in asymmetric synthesis.

In terms of synthesis, researchers have developed innovative methods to produce this compound with high yield and purity. For example, a 2023 study reported a one-pot synthesis involving a palladium-catalyzed cross-coupling reaction, which not only simplifies the production process but also reduces environmental impact. Such advancements underscore the importance of green chemistry principles in modern synthetic strategies.

The biological activity of (R)-2-Amino-3-(4-(benzyloxy)phenyl)propanoic acid has been extensively studied. Preclinical trials have demonstrated its potential as an anti-inflammatory agent, with studies showing significant reduction in inflammation markers in animal models. Additionally, its antioxidant properties make it a promising candidate for use in cosmetics and nutraceuticals.

From an applications perspective, this compound is being explored for its role in peptide therapeutics. Its ability to form stable amide bonds with other amino acids makes it a valuable component in peptide synthesis. Furthermore, its compatibility with solid-phase synthesis techniques has facilitated its integration into large-scale production processes.

Looking ahead, ongoing research is focused on optimizing the compound's pharmacokinetic profile to enhance its therapeutic efficacy. Collaborative efforts between academic institutions and pharmaceutical companies are paving the way for clinical trials targeting specific indications such as neurodegenerative diseases and chronic inflammatory conditions.

In conclusion, (R)-2-Amino-3-(4-(benzyloxy)phenyl)propanoic acid (CAS No. 65733-15-5) represents a versatile and promising molecule with wide-ranging applications across multiple disciplines. Its unique chemical properties, combined with recent advancements in synthesis and application techniques, position it as a key player in future innovations within the chemical and pharmaceutical industries.

• 52799-86-7(h-tyr-obzl)
• 32795-52-1((S)-2-Amino-3-(4-ethoxyphenyl)propanoic acid)
• 16652-64-5(O-Benzyl-L-tyrosine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)